beta Subunit Thyrotropin (Thyrotropin-beta)

Subscribe to Selected New Research on beta Subunit Thyrotropin

111 relevant articles (2 outcomes, 12 trials/studies) found for this Bio-Agent

Description: The beta subunit of thyroid stimulating hormone, thyrotropin. It is a 112-amino acid glycopolypeptide of about 16 kD. Full biological activity of TSH requires the non-covalently bound heterodimers of an alpha and a beta subunit.

Also Known As:

Thyrotropin-beta; Thyrotropin, beta Subunit; TSH, beta Chain; TSH-beta; TSHB Gene Product; Thyrotropin, beta Chain; Thyrotropin, beta Polypeptide Chain; TSH beta; Thyrotropin beta; TSH, beta Subunit; Thyroid Stimulating Hormone, beta Subunit

Relationship Network

Bio-Agent Context: Research Results

Hormones, Hormone Substitutes, and Hormone Antagonists

Hormones: 46253

Peptide Hormones: 377

Pituitary Hormones: 370

Anterior Pituitary Hormones: 108

Thyrotropin: 3807

beta Subunit Thyrotropin: 111

Amino Acids, Peptides, and Proteins

Peptides: 16375

Peptide Hormones: 377

Pituitary Hormones: 370

Anterior Pituitary Hormones: 108

Thyrotropin: 3807

beta Subunit Thyrotropin: 111

Experts

1.	Domené, Horacio M: 2 articles (01/2004 - 06/2003)
2.	Heinrich, Juan J: 2 articles (01/2004 - 06/2003)
3.	Chiesa, Ana: 2 articles (01/2004 - 06/2003)
4.	Sippell, W G: 1 article (05/2006)
5.	Pohlenz, J: 1 article (05/2006)
6.	Krone, N: 1 article (05/2006)
7.	Riepe, F G: 1 article (05/2006)
8.	Partsch, C-J: 1 article (05/2006)
9.	Osamura, Robert Yoshiyuki: 1 article (11/2005)
10.	Lloyd, Ricardo V: 1 article (11/2005)

Related Diseases

1.	Neoplasms (Cancer) 01/01/1992 - "A cell line (alpha TSH) derived from the transplantable mouse thyrotropic tumor MGH101A, which no longer expresses the TSH beta-subunit gene but continues to secrete large amounts of alpha-subunit, was used as a model to study alpha-subunit gene expression independent from the TSH beta-subunit gene and was compared with the expression in TSH-secreting TtT97 tumors. " 04/16/1991 - "Our previous studies demonstrated TRH stimulation of TSH beta gene expression in rat pituitary cell cultures and GH3 tumor cells in a transient expression assay. " 12/01/1987 - "The current studies reveal that expression of the mouse TSH beta-subunit gene in the pituitary gland and TtT97 murine thyrotropic tumor results in multiple mRNAs which arise by alternative splicing. " 09/01/2004 - "The tumor cells displayed positive reaction for TSH (beta-subunit). " 01/05/1996 - "We have utilized the thyrotrope-derived TtT-97 thyrotropic tumors to investigate tissue-specific expression of the TSH beta promoter. " Order ALL the reference details at left...
2.	Hyperthyroidism 04/01/1988 - "A significant reduction in the pituitary TSH-beta mRNA levels was observed in all NTI models and hyperthyroidism, while TSH-beta mRNA was increased in thyroidectomized rats. " 12/01/1996 - "Pituitary adenomas and activating mutations of the TSH receptor gene (Parma et al., 1993) cause hyperthyroidism and TSH beta gene defects (Hayashizaki et al., 1989) and inactivating mutations of the TSH receptor gene (Sunthornthepvarakul et al., 1995) cause hypothyroidism. " Order ALL the reference details at left...
3.	Adenoma (Adenomas) 05/01/1998 - "Nine clinically non-functioning adenomas expressed Pit-1 as well as GH, PRL and/or TSH beta, thus having somatomammotrophic or thyrotrophic properties, 3 of which overlapped with the above DAX-1-expressing adenomas. " 04/01/1998 - "TSH beta-positive adenoma cells were less frequently seen than GH-positive adenoma cells. " 12/01/1994 - "The proportion of TSH beta-positive cells ranged from 20% to 75% of adenoma cells. " 02/01/1993 - "These adenomas were composed of enlarged round cells which were positive only for GH, hGRF, PRL and TSH beta SU. " 01/20/1987 - "The immunoperoxidase technique revealed TSH beta in the cytoplasm of some adenoma cells. " Order ALL the reference details at left...
4.	Pituitary Neoplasms (Pituitary Adenoma) 08/01/1995 - "The tissues from pituitary adenomas were obtained at the time of transsphenoidal surgery and revealed immunohistochemically the expression of alpha-subunit and TSH beta in all patients. " 09/05/1989 - "Reduced expression of TSH beta constructs was also found in GH3 and GH4 pituitary tumor lines. " 06/01/1989 - "Pituitary adenoma tissue obtained at the time of transsphenoidal surgery immunostained weakly with anti-TSH beta serum and strongly with anti-alpha-subunit serum. " 06/01/1990 - "These findings support the idea that some pituitary adenomas in acromegaly cosecrete GH and either alpha subunit or TSH-beta subunit." 11/01/2005 - "Induction of GH, PRL, and TSH beta mRNA by transfection of Pit-1 in a human pituitary adenoma-derived cell line." Order ALL the reference details at left...
5.	Hypothyroidism 06/01/2003 - "Congenital secondary hypothyroidism due to a mutation C105Vfs114X thyrotropin-beta mutation: genetic study of five unrelated families from Switzerland and Argentina." 05/01/2006 - "Initially elevated TSH and congenital central hypothyroidism due to a homozygous mutation of the TSH beta subunit gene: case report and review of the literature." 08/01/2004 - "Four new cases of congenital secondary hypothyroidism due to a splice site mutation in the thyrotropin-beta gene: phenotypic variability and founder effect." 04/01/2004 - "Hypothyroidism in siblings due to a homozygous mutation of the TSH-beta subunit gene." 01/01/2004 - "The C105fs114X is the prevalent thyrotropin beta-subunit gene mutation in Argentinean patients with congenital central hypothyroidism." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Messenger RNA (mRNA)
2.	Growth Hormone (Somatotropin)
3.	DNA (Deoxyribonucleic Acid)
4.	beta Subunit Thyrotropin (Thyrotropin-beta)
5.	Thyrotropin (Thyroid-Stimulating Hormone)
6.	Hormones
7.	beta Subunit Luteinizing Hormone
8.	Complementary DNA (cDNA)
9.	Somatostatin Receptors (Somatostatin Receptor)
10.	Octreotide (Sandostatin)

Related Therapies and Procedures

1.	Aftercare (After-Treatment)

Best Treatments:
Research Summary Report
on Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 20112 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>